Summary
Schizophrenia remains a relatively common debilitating and stigmatising disorder, whose precise aetiology is unknown. Research has consistently shown a strong genetic component, although environmental factors are also implicated. A number of biochemical aetiological theories have been proposed but the most plausible is the dopamine hypothesis. This suggests that there is excess activity at central dopaminergic pathways in the brain. Certainly, all effective antipsychotic drugs have dopamine blocking properties.
Management of this disorder includes admitting new cases to hospital for careful evaluation by a multidisciplinary team. Although the mainstay of treatment is antipsychotic (neuroleptic) medication, social interventions are also required. These include close liaison with the patient’s family, which can help to prevent relapse and aid compliance with drug treatment. Modern therapy aims for recovery of social and occupational skills and gradual rehabilitation back into the community.
Similar content being viewed by others
References
Davison K, Bagley CR. Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature. In Herrington RN (Ed.) Current problems in neuropsychiatry: schizophrenia, epilepsy and the temporal lobe, Headley Bros, Ashford, 1969
Gottesman II, Shields J. Schizophrenia: the epigenetic puzzle. Cambridge University Press, Cambridge, 1982
Heston LL. Psychiatric disorders in foster home reared children of schizophrenic mothers. British Journal of Psychiatry 112: 819–825,1966
Kety SS, Rosenthal D, Wender PH, Schulsinger F, Jacobsen B. Mental illness in the biological and adoptive families of individuals who have become schizophrenic. Behavior Genetics 6: 219–225, 1976
McGuffin P. Genetic influences on personality, neurosis and psychosis. In McGuffin et al. (Eds) Scientific principles of psychopathology pp. 191–226, Grune & Stratton, London, 1984
Murphy DL, Wyatt RJ. Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature 238: 225–226,1972
O’Rourke DH, Gottesman II, Suarez BK, Rice J, Reich T. Refutation of the single locus model in the aetiology of schizophrenia. American Journal of Human Genetics 33: 630–649, 1982
Osmond H, Smythies JR. Schizophrenia: a new approach. Journal of Mental Science 98: 309–315, 1952
Reveley MA, Campbell IC. Neurochemistry, In McGutfin et al. (Eds) Scientific principles of psychopathology, pp. 57–95, Grune & Stratton, London, 1984
Saavedra JM, Axelrod J. Psychomimetic N-methylated tryptamines: formation in brain in vivo and in vitro. Science 175: 1365–1366, 1952
Slater E Beard AW, Glithero E. The schizophrenia-like psychoses of epilepsy. British Journal of Psychiatry 109: 95–150, 1963
Wender PH, Rosenthal D, Kety S, Schulsinger F, Welner J. Social class and psychopathology in adoptees: a natural experimental method for separating the roles of genetic and environmental factors. Archives of General Psychiatry 28: 318–325, 1973
Vaughan CE, Leff JP. The influence of family and social factors on the course of psychiatric illness. British Journal of Psychiatry 129: 125–137, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farmer, A.E., McGuflin, P. The Pathogenesis and Management of Schizophrenia. Drugs 35, 177–185 (1988). https://doi.org/10.2165/00003495-198835020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198835020-00006